An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema).
Apple may increase iPhone 17 prices in India as strong demand and low stock combine with rising component costs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback